CS Paper Radar

Neural Supervised Clustering for Learning Individualized Treatment Rules with Many Treatments

Daixi Huang, Yixin Yuan, Yifan Dai, Yufeng Liu

cs.LG stat.MLstat.ME ·submitted 2026-10-13 19:40 UTC · v1

Abstract

Learning an individualized treatment rule (ITR) with many treatments requires estimating treatment-specific effects from limited observations per arm. Treatments with similar conditional responses can share information, but linear contrast models may miss nonlinear heterogeneity. We propose nonlinear supervised clustering fusion (NSCF), a neural Q-learning framework with a shared nonlinear covariate representation and low-dimensional treatment embeddings. Pairwise fusion groups treatments with similar learned contrasts, yielding an ITR and an interpretable partition. An alternating algorithm combines neural training, embedding fusion, validation-based partition selection, and unpenalized grouped refitting. NSCF lowers regret relative to a strong neural reference in nonlinear exact-sharing simulations; perturbations characterize the limits of hard sharing. In a melanoma xenograft application, NSCF improves average policy value over the neural reference. These results support nonlinear representation learning with supervised treatment fusion when treatment effects exhibit shared structure.

Comment
13 pages, 6 figures

Closest papers

Nearest neighbours by meaning across the whole index.

Learning Across Heterogeneous Feature Spaces with Group Robustness

cs.LG ·2026-11-06 ·Xenia Konti, Arjun Tschand, Chuan Hong, Nicoleta J. Economou-Zavlanos, Michael M. Zavlanos
hot direction similarity 0.61
Abstract · 29 pages, 5 figures

In clinical applications, patients undergo different combinations of tests, and machine learning models must therefore ensure accurate predictions across heterogeneous feature spaces. Current approaches upweight the patients with the highest loss, without accounting for the limited predictive information in their features preventing their loss from going any lower. Moreover, when patients' feature spaces are fully disjoint, current methods reduce to training independent models, preventing knowledge transfer across them. We propose a framework for group robust learning across heterogeneous feature spaces, where groups are patients sharing a feature space. Since a high loss may simply reflect uninformative features, we instead optimize for worst-group excess loss, the gap between a group's loss and an estimate of its achievable optimum. To allow collaboration between groups, we use group-specific encoders mapping into a shared latent space in which learnable Gaussian anchors cluster patients by outcome. On tabular and imaging medical datasets, including fully disjoint feature settings, our framework outperforms state-of-the-art methods when groups differ in their optimal losses or cannot train a good model on their own, reducing worst-group loss by up to 79% and excess loss by up to 95% with up to 18$\times$ fewer parameters.

0.34

PerturbRx: Learning Treatment-Conditioned Latent Transitions for Patient Drug Response Prediction

cs.LG q-bio.QM ·2026-08-21 ·Yoshitaka Inoue, Minoh Jeong, Alfred Hero, Rui Kuang, Augustin Luna
similarity 0.61
Abstract

Scarce data and tumor heterogeneity limit patient-level cancer treatment-response prediction. Existing approaches predict response from pretreatment molecular profiles and drug representations, without explicitly modeling the molecular changes expected under treatment. We propose PerturbRx, a treatment-conditioned representation learning framework that learns intervention-induced latent transitions and uses them as patient-drug response features. PerturbRx trains a drug- and dose-conditioned transition predictor from context-matched but cell-unpaired control and treated single-cell populations, then freezes and transfers the predictor to pretreatment patient profiles without requiring post-treatment measurements. The transition is combined with patient and drug representations to predict response. Across TCGA and patient-derived xenograft benchmarks, PerturbRx achieves the strongest aggregate predictive performance among the evaluated methods. These results support perturbation-pretrained latent transitions as useful representations for patient-level drug-response prediction.

0.25

MOSAIC: Modality-agnostic Spectral Alignment for Federated Image-level Weakly Supervised Tumor Segmentation under Client-specific Missing Modalities

eess.IV cs.CV ·2026-08-20 ·Tarun Kumar Garg, Vaanathi Sundaresan
code/data similarity 0.59
Abstract

Trustworthy multimodal fusion in clinical settings requires handling incomplete and heterogeneous modality subsets across institutions, where privacy constraints prohibit centralized data sharing. Federated learning (FL) mitigates data-sharing constraints but suffers from client-specific missing modalities, where institutions possess incomplete multimodal subsets, degrading fusion quality and segmentation performance. While FL and weak supervision have been studied separately, their joint use with image-level labels under heterogeneous missing modalities remains unaddressed. We propose \textbf{MOSAIC}, the first modality-agnostic federated framework for weakly supervised binary tumor segmentation under client-specific missing modalities. We introduce a client-specific modality-alignment module that fuses available channels into a shared latent space without prior knowledge of modality identity, a spectral prototype alignment loss that reconciles cross-client distribution shift using compact non-invertible frequency-domain statistics, and a dedicated federated refinement network that denoises the resulting CAM pseudo-labels into accurate masks, breaking the accuracy ceiling of weak supervision. Experiments on three multi-institutional brain tumor benchmarks (FeTS2022, BraTS-MEN, and BraTS-SSA) demonstrate significant improvements over all image, box, and point-supervised baselines, approaching fully supervised accuracy using only image-level labels and reaching 0.84 Dice on FeTS2022. Dynamic new client addition enables previously unseen institutions to join an already-trained federation within 0.01-0.04 Dice without retraining. Code is available at https://github.com/Tarun2201/MOSAIC.

0.24

PerturbJEPA: Joint-Embedding Predictive Learning of Cellular Perturbation Responses

cs.CV ·2026-11-16 ·Jiangshuan Pang, Youzhe He, Yiting Deng, Wangyang Tang, Huinan Xu +3 more
code/data similarity 0.58
Abstract · 23 pages, 6 figures, 14 tables. Code: https://github.com/BGI-Hangzhou-OmicsAI/PerturbJEPA

Identifying the drug and dose that produced a cellular response requires preserving treatment effects within each cellular background. A joint-embedding predictor can match its targets while ignoring the intervention if its encoder preserves differences across backgrounds but erases differences between treated and control populations within each one. We call this failure interventional contrast collapse. PerturbJEPA encodes the difference in mean gene expression between treated and control populations as an effect vector. It aligns the displacement between their latent centroids with this vector and regularizes the vectors to preserve variation across population pairs. We show that the measured displacements cannot all coincide within a batch when effect-vector variation exceeds the root-mean-square alignment error. Trained with separate drug and dose ranking objectives, the model predicts candidate responses from a common control population and matches them to the observed response without cell pairing or expression reconstruction. We evaluate 3,592 Tahoe-100M queries on held-out combinations of known interventions and cellular backgrounds, each with over 700 drug-dose candidates in a fixed, background-specific catalog. PerturbJEPA achieves 91.46% macro joint drug-dose Recall@1, exceeding STATE by 3.40 percentage points (95% drug-cluster bootstrap interval of 1.72 to 5.07 points). Controlled diagnostics show that treatment-control differences can shrink even when representations remain globally dispersed. With the drug ranking objective fixed, adding effect-vector regularization to alignment raises joint Recall@1 from 18.57% to 87.47%.

0.54

Bison: Cross-Dataset Learning for Unseen-Compound Perturbation Prediction

cs.LG cs.AI ·2026-09-26 ·Yunfan Liu, Kasra Ghorbani, Yufei Huang, Zicheng Liu, Jiangbin Zheng +4 more
benchmark similarity 0.58
Abstract

Predicting transcriptional responses to unseen compounds is limited by fragmented chemical coverage and heterogeneous experimental platforms and gene panels. To assess molecular generalization across these settings, we build on Chem-PerturBridge to benchmark eight datasets with 16,771 compounds, withholding test compounds from every training dataset. This comparison reveals that high overall response agreement can coexist with weak prediction of drug-specific differences, despite reproducible signals across repeated measurements. To exploit complementary chemical supervision while targeting these differences, we introduce Bison: a shared gene representation connects native panels, while two discrete diffusion models compose context-dependent responses with molecular deviations learned through matched drug-contrast supervision. A single Bison model jointly trained across all eight datasets achieves the highest mean overall-response and drug-contrast Pearson correlations on the full benchmark in comparison with 11 methods trained independently per dataset. Compared with dataset-specific training of the same architecture, joint training increases mean drug-contrast correlation by 27.4\%, with gains across all eight datasets and improvements in overall response prediction. These results demonstrate how matched drug contrasts turn complementary screens into shared molecular supervision for unseen-drug response prediction while preserving native gene measurements.

0.14

SYNPRED: A Synergistic Approach to Multimodal Learning for Clinical Prediction

cs.LG cs.CV ·2026-10-13 ·Ivana Janíčková, Yen Y. Tan, Thomas H. Helbich, Philipp Seeböck, Julieta Di Marco +4 more
top venuecode/data similarity 0.56
Abstract

Multimodal medical data captures complementary aspects of disease. It provides a comprehensive basis for diagnosis and the identification of biological associations linked to progression or treatment response. Established contrastive learning approaches exploit shared information across modalities, but fall short in exploiting complementary, modality-specific signals relevant for a task. Here, we propose a synergistic multimodal variational autoencoder (VAE) framework that separates task-relevant unimodal and multimodal information from instance-specific variation task-irrelevant, allowing complementary signals across modalities to be leveraged for prediction. The method yields benefits even if modalities are missing at test time. We evaluate the method on a treatment response prediction task using medical imaging and RNA data. Empirical comparison with alignment-based and multimodal VAE state-of-the-art approaches demonstrates improved multimodal prediction performance, and consistent benefits for prediction from a single modality after multimodal training. The full code can be found here: https://github.com/cirmuw/SYNPRED.

0.41

SIRNET: Causal Adaptation of Pretrained Embeddings for Semiparametric Treatment-Effect Estimation Under Surrogacy

cs.LG stat.ME ·2026-09-29 ·Lei Shi, Qiuran Lyu
similarity 0.56
Abstract

Modern experiments increasingly produce rich post-treatment objects---such as text, images, and video---that may provide early surrogate signals for outcomes that are delayed, expensive, or observed only for a subset of participants. A pretrained encoder can turn such an object into a strong generic embedding, but the embedding is not trained for the estimation tasks required by a causal estimator and may emphasize information irrelevant to the causal target. We propose SIRNET, a Surrogate-Informed Representation adaptation framework for neural-NETwork-based causal estimation in the presence of unstructured post-treatment surrogates. Starting from pretrained surrogate embeddings, SIRNET learns a shared adapter jointly for outcome prediction, treatment propensity, and arm-specific surrogate marginalization, beyond the generic pretraining objective. The resulting covariate and surrogate representations provide a common interface for these nuisance tasks. The final treatment-effect estimate and confidence interval are obtained from cross-fitted orthogonal scores that attain the semiparametric efficiency bound under the stated nuisance-rate conditions. We also validate SIRNET's performance in synthetic and semisynthetic experiments, as well as the Anti-Amyloid in Asymptomatic Alzheimer's Disease (A4) trial, using frozen pretrained brain-MRI embeddings as surrogates for a long-term outcome.

0.26

Progressive multi-scale tumor-state memory for incomplete multimodal brain tumor segmentation

eess.IV cs.CV ·2026-10-19 ·Milad Rostamian, Mohammadreza Mohammadi, Mohsen Soryani
similarity 0.56
Abstract

Brain tumor segmentation uses complementary magnetic resonance imaging (MRI) sequences, but some sequences may be unavailable in practice. Their absence changes the information available for segmenting different tumor regions. Fusion methods can support different input subsets. However, fusion at several scales does not by itself specify how tumor evidence is retained and updated to guide fusion at later stages. We propose a progressive multi-scale tumor-state memory network (PMTM) for segmentation from any non-empty subset of T1ce, T1, FLAIR, and T2. PMTM maintains a compact state for the current subject across the encoder stages. At each stage, we use assignment maps to pool spatial features into ordered evidence vectors for each available modality. We average these vectors across the available modalities, and a learned gate combines this evidence with the previous state. The up- dated state guides residual fusion at that stage and is used in the state update at the next stage. A modality-token mixer also models interactions among the available modalities at each stage. We apply semantic supervision to the assignment maps at all four stages. We evaluate PMTM on BraTS2018, BraTS2020, and BraTS2023 GLI across all 15 non-empty modality subsets. Averaged over the three tumor regions and the 15 subsets, PMTM achieves Dice scores of 75.31%, 77.54%, and 80.47% on BraTS2018, BraTS2020, and BraTS2023 GLI, respectively. These scores are higher than those of RobustSeg, RFNet, and mmFormer in our experiments on each dataset. Component ablations and internal state analysis are performed on BraTS2020.

0.06